Horizon Technology Finance (HRZN) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates several negative factors: declining NII and NAV, lower interest income, and management's evasive answers on nonaccruals and losses. Despite some positive elements like increased originations and a strong liquidity position, the overall financial performance shows weaknesses. The merger with MRCC is promising but not immediate. Additionally, the sentiment from the Q&A reveals concerns about income sustainability and transparency. These factors, combined with the lack of immediate catalysts, suggest a negative stock price reaction in the near term.
Key Financial Performance
Net Investment Income (NII) $0.18 per share for Q4 2025, compared to $0.32 per share in Q3 2025 and $0.27 per share in Q4 2024. The decrease was primarily due to lower prepayment activity and associated income.
Net Asset Value (NAV) $6.98 per share as of December 31, 2025, compared to $7.12 as of September 30, 2025, and $8.43 as of December 31, 2024. The reduction was primarily due to paid distributions exceeding NII.
Portfolio Yield on Debt Investments 14.3% for Q4 2025, compared to 14.9% in Q4 2024. The decrease was attributed to a lower level of prepayments during the quarter.
Debt Investment Portfolio $602 million on a net cost basis as of December 31, 2025, up 3% from $585 million as of September 30, 2025. The increase was due to new originations offset by scheduled principal payments and prepayments.
New Originations $103 million in Q4 2025, offset by $13 million in scheduled principal payments and $50 million in principal prepayments, refinancings, and partial paydowns.
Committed and Approved Backlog $154 million as of December 31, 2025, compared to $119 million as of September 30, 2025. The increase was due to new commitments and pipeline growth.
Investment Income $21 million for Q4 2025, compared to $24 million in Q4 2024. The decrease was primarily due to lower interest income on the debt investment portfolio.
Expenses $12.5 million for Q4 2025, compared to $12.8 million in Q4 2024. Interest expense was $8 million, $0.2 million lower than Q4 2024, and base management fees were $2.9 million, $0.2 million lower than the prior year.
Liquidity $189 million as of December 31, 2025, consisting of $143 million in cash and $46 million in funds available under existing credit facilities.
Debt-to-Equity Ratio 1.5:1 as of December 31, 2025, with net leverage at 1.05:1 after netting out cash on the balance sheet.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Merger with MRCC: The merger with MRCC, delayed into 2026 due to a government shutdown, is expected to significantly increase Horizon's equity capital for investment in earning assets and achieve greater economies of scale.
Venture Loan to Ossio: Horizon co-invested with Monroe Capital in a venture loan to Ossio, showcasing the synergistic efforts post-merger.
Venture Debt Market: Horizon is targeting larger venture loans to early and later-stage venture capital and institutional-backed companies, as well as small-cap public companies.
AI and Defense Technology: Horizon is conducting deep due diligence in AI and defense technology sectors to identify future investment opportunities.
Portfolio Growth: Horizon funded 9 debt investments totaling $103 million in Q4 2025, with a committed and approved backlog of $154 million.
Debt Portfolio Yield: Achieved a portfolio yield on debt investments of over 14% for Q4 and nearly 16% for the full year 2025, among the highest in the BDC industry.
Liquidity and Leverage: Ended 2025 with $189 million in available liquidity and a net leverage ratio of 1.05:1, below the target leverage.
Focus on Venture Debt: Horizon aims to be a key supplier of venture debt capital, leveraging its strong pipeline and Monroe Capital's backing to compete for larger, high-quality opportunities.
AI Risk Assessment: Horizon and Monroe Capital are focusing on AI-related risks in their underwriting process, balancing optimism and caution in the tech sector.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Government Shutdown Impact: The government shutdown in Q4 2025 delayed the merger with MRCC into 2026, potentially impacting the company's ability to increase equity capital and achieve economies of scale in a timely manner.
Prepayment Activity: Lower prepayment activity in Q4 2025 reduced associated income, which may continue to remain modest in the near term, impacting net investment income (NII).
Portfolio Credit Quality: 13% of the portfolio's fair value was rated 2 or 1 as of December 31, 2025, indicating some credit risk within the portfolio.
Interest Rate Environment: Approximately 71% of floating-rate debt investments are at their interest rate floors, which could limit income growth if interest rates decrease.
Life Science IPO Market: The limited life science IPO market creates challenges for exit opportunities, though it also presents venture loan origination opportunities.
AI-Related Risks: AI-related risks are a central focus in underwriting, with potential challenges in navigating the evolving AI landscape and its impact on enterprise software investments.
Debt-to-Equity Ratio: The debt-to-equity ratio stood at 1.5:1 as of December 31, 2025, which, while below the target leverage on a net basis, indicates a reliance on debt for growth.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Merger with MRCC: The merger with MRCC is expected to significantly increase Horizon's equity capital available for investment in earning assets and allow it to take advantage of greater economies of scale. The merger is anticipated to close in early 2026, pending shareholder approval.
Post-Merger Synergies: Post-merger, Horizon expects a more coordinated and synergistic effort with Monroe Capital, enabling larger venture loans to early and later-stage venture capital and institutional-backed companies, as well as small-cap public companies.
Portfolio Growth: Horizon plans to grow its portfolio in 2026, leveraging a strong committed backlog of $154 million and a robust pipeline of venture debt opportunities. The company expects to originate larger venture loans and increase net investment income (NII) over time.
Venture Debt Market Outlook: The demand for venture debt capital remains high, and Horizon expects to be a key supplier of such capital in 2026 and beyond. The company sees opportunities in tech and life sciences, particularly in AI and defense technology.
Financial Projections: Horizon anticipates generating NII at or above declared distributions over time, supported by a high portfolio yield and strong liquidity. The company declared monthly distributions of $0.06 per share for April, May, and June 2026.
Investment Capacity: As of December 31, 2025, Horizon had $472 million in potential new investment capacity, supported by $189 million in available liquidity and borrowing capacity under credit facilities.
Interest Rate Environment: Approximately 71% of Horizon's floating-rate debt investments are at their interest rate floors, which should mitigate the impact of decreasing interest rates.
AI and Technology Investments: Horizon is conducting deep due diligence in AI and defense technology sectors to identify high-quality investment opportunities. The company views AI as a transformative area with significant potential for future investments.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Monthly Distributions: The Board declared regular monthly distributions of $0.06 per share payable in April, May, and June of 2026.
Undistributed Spillover Income: The company's undistributed spillover income as of December 31, 2025, was $0.65 per share.
Merger with MRCC: The anticipated merger with MRCC is expected to significantly increase Horizon's equity capital available for investment in earning assets.
Portfolio Growth and NII: The merger is expected to allow Horizon to originate larger venture loans, grow its portfolio, and increase net investment income (NII) over time.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How was the new dividend level decided?
A:The distribution level is reviewed quarterly with the Board, considering the current portfolio, run rate, spillover, pipeline, and growth opportunities to determine a sustainable level.
Q:What is the percentage at the contractual floor?
A:71%.
Q:What drove the lower interest income quarter-over-quarter?
A:The major impact was due to prepayment activity. Significant prepayments and refinancing in Q3 led to higher income, while Q4 had fewer prepayments and lower income from opportunistic refinancing.
Q:Does the $102 million of originations this quarter include refinancing within the portfolio?
A:Yes, it included a couple of refinancing. These refinancings accelerate fee income on previous debt investments but result in lower income compared to prepayments.
Q:What is the opportunity for public company financing?
A:The opportunities include refinancing or providing new capital. Many companies are unaware of the option to use debt capital, which is less dilutive than equity issuance. This creates a fertile market for flexible capital structures.
Q:What is the status of the three remaining portfolio companies on nonaccrual?
A:The company is working on maximizing recoveries for each nonaccrual. Details are limited as these are private companies.
Q:What caused the decline from four to three nonaccruals?
A:An acquisition completed this quarter resulted in the removal of one nonaccrual. The company received the fair value amount with no NAV impact.
Q:Was the driver of the realized loss in exits from Tallac Therapeutics?
A:Tallac Therapeutics was a small part of the realized loss. The losses were realized at the fair value going into the quarter.
Q:How much of the 4.875% 2026 notes has been redeemed?
A:The full amount was redeemed in January.
Q:Is management aiming to support the $0.33 dividend through 2026?
A:The adviser agreed to waive $4 million of fees over four quarters and has a repurchase program in place to support the shares.
Q:Should the new dividend be seen as a reasonable earnings run rate for the company?
A:The distribution level is set at a level believed to be sustainable over time, reviewed with the Board.
Q:What was the conversion rate for the convertible conversion this quarter, and is there any dilutive impact?
A:Conversions are done at NAV, and the $8.5 million converted in Q4 had no dilution.
Q:Review of Unclear Management Responses
A:Management avoided providing detailed information on the status of nonaccrual portfolio companies and the specifics of realized losses from private companies, citing confidentiality.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI
BDC industry
Capital
Finance Conference
IPO market
IPOs
Officer Seitz
Pelthos
Seitz Chief
backlog end
cap company
commitment
company portfolio
end portfolio
environment
exit
factor
interest
investment venture
lending market
loan opportunity
meeting
merger MRCC
note
opportunity investment
option
platform
portfolio company
portfolio debt
portfolio quarter
portfolio venture
portfolio yield
prepayment
proceeds
progress
record
refinancings
respect
scale
software
tech
venture lending
venture loan
week
HRZN Transcript
Dexterra Group Inc. (DXT:CA) Q4 2025 Earnings Call Transcript
Positive3-4
The earnings call highlights strong financial performance with revenue and EBITDA growth, improved margins, and a robust pipeline in venture lending and support services. The Q&A section reveals positive sentiment towards growth in defense and infrastructure sectors and an optimistic outlook for the U.S. IFM market. Despite some concerns about ABS revenue variability and unclear guidance on PVC equity income, the overall sentiment is positive, supported by strategic acquisitions and a focus on debt reduction. The lack of market cap details suggests a moderate reaction, predicting a 2%-8% stock price increase.
Horizon Technology Finance (HRZN) Q4 2025 Earnings Call Transcript
Unknown3-4
The earnings call indicates several negative factors: declining NII and NAV, lower interest income, and management's evasive answers on nonaccruals and losses. Despite some positive elements like increased originations and a strong liquidity position, the overall financial performance shows weaknesses. The merger with MRCC is promising but not immediate. Additionally, the sentiment from the Q&A reveals concerns about income sustainability and transparency. These factors, combined with the lack of immediate catalysts, suggest a negative stock price reaction in the near term.
Horizon Technology Finance (HRZN) Q3 2025 Earnings Call Transcript
Positive10-29
The earnings call summary indicates strong financial performance with increased investment income and reduced expenses. The merger with Monroe Capital Corporation is expected to provide significant capital infusion, cost savings, and portfolio diversification, enhancing Horizon's market position. Although there were some unclear management responses, the overall sentiment from the Q&A was positive, with expectations for leverage targets to be met soon and sustainable yields. The strategic plan and financial health suggest a positive stock price movement in the short term.
Horizon Technology Finance (HRZN) Q2 2025 Earnings Call Transcript
Unknown8-7
The earnings call summary provides a mixed outlook with both positive and negative elements. The partnership with Wendel Group and increased investment capacity are positive, but the decline in NAV and potential operational cost savings not materializing are concerning. The Q&A section reveals some uncertainties, particularly in management's lack of specific targets and plans. The merger provides a premium to MRCC shareholders and is cost-efficient for Horizon, but there are risks in portfolio diversification. Overall, the sentiment is neutral, reflecting balanced positive and negative factors with no clear catalyst for significant stock movement.
HRZN Slides
HRZN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
